Atrys Health, S.A. (BME:ATRY)
Spain · Delayed Price · Currency is EUR 2.890
-0.035 (-1.20%)
Apr 28, 2026, 1:20 PM CET
Atrys Health Market Cap
Atrys Health has a market cap or net worth of €222.03 million as of April 28, 2026. Its market cap has increased by 2.98% in one year.
Market Cap
222.03M
Enterprise Value
466.41M
Revenue
144.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.89
Market Cap Chart
Since July 22, 2016, Atrys Health's market cap has increased from 17.85M to 222.03M, an increase of 1,144.18%. That is a compound annual growth rate of 29.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 222.03M | -0.13% |
| Dec 31, 2025 | 222.31M | -13.13% |
| Dec 31, 2024 | 255.91M | -8.07% |
| Dec 29, 2023 | 278.37M | -39.03% |
| Dec 30, 2022 | 456.55M | -26.48% |
| Dec 30, 2021 | 620.95M | 107.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.57B |
| Laboratorios Farmaceuticos Rovi | 4.13B |
| Almirall | 2.70B |
| Pharma Mar | 1.68B |
| Clínica Baviera | 848.98M |
| Prim, S.A. | 227.13M |
| Laboratorio Reig Jofre | 219.00M |
| Oryzon Genomics | 217.97M |